Literature DB >> 15308139

Moderated 252Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose.

Mark J Rivard1, Robert G Zamenhof.   

Abstract

While there is significant clinical experience using both low- and high-dose (252)Cf brachytherapy, combination therapy using (10)B for neutron capture therapy-enhanced (252)Cf brachytherapy has not been performed. Monte Carlo calculations were performed in a brain phantom (ICRU 44 brain tissue) to evaluate the dose enhancement predicted for a range of (10)B concentrations over a range of distances from a clinical (252)Cf source. These results were compared to experimental measurements and calculations published in the literature. For (10)B concentrations </=50 microg/g, the (10)B neutron capture dose enhancement was small in comparison to the (252)Cf fast neutron dose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308139     DOI: 10.1016/j.apradiso.2004.05.017

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  Tissue composition effect on dose distribution in neutron brachytherapy/neutron capture therapy.

Authors:  Mohsen Khosroabadi; Bagher Farhood; Mahdi Ghorbani; Nima Hamzian; Homa Rezaei Moghaddam; David Davenport
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-10

2.  Effect of diameter of nanoparticles and capture cross-section library on macroscopic dose enhancement in boron neutron capture therapy.

Authors:  Bagher Farhood; Mahdi Ghorbani
Journal:  J Contemp Brachytherapy       Date:  2014-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.